Abstract
Purpose
The aim of this study was to compare the diagnostic accuracy of 2-[fluorine-18] fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG-PET) and computed tomography (CT) with PET/CT in the detection of liver metastases during tumour staging in patients suffering from colorectal carcinoma for the purposes of correct surgical planning and follow-up.
Materials and methods
A total of 467 patients underwent a PET/CT scan using an iodinated contrast medium. We compared images obtained by the single PET scan, the single CT scan and by the fusion of the two procedures (PET/CT). The final diagnosis was obtained by histological examination and/or by the follow-up of all patients, including those who did not undergo surgery or biopsy.
Results
The PET scan had 94.05% sensitivity, 91.60% specificity and 93.36% accuracy; the CT scan had 91.07% sensitivity, 95.42% specificity and 92.29% accuracy. The combined procedures (PET/CT) had the following values: sensitivity 97.92%, specificity 97.71% and accuracy 97.86%.
Conclusions
This study indicates that PET/CT is very useful in staging and restaging patients suffering from colorectal cancer. It was particularly useful when recurrences could not be visualised either clinically or by imaging despite increasing tumour markers, as it guaranteed an earlier diagnosis. PET/CT not only provides high diagnostic performance in terms of sensitivity and specificity, enabling modification of patient treatment, but it is also a unique, high-profile procedure that can produce cost savings.
Riassunto
Obiettivo
Comparare l’accuratezza diagnostica della 18F-FDG-PET e della TC con quella della PET/TC nel rilievo di metastasi epatiche in pazienti affetti da carcinoma del colon-retto in fase di staging ai fini di un corretto planning chirurgico e follow-up.
Materiali e metodi
Sono stati valutati 467 pazienti mediante PET/TC effettuata con somministrazione di MdC organoiodato. È stata effettuata una comparazione tra le immagini ottenute dalla sola rilevazione PET, dalla sola rilevazione TC e quelle ottenute mediante fusione PET/TC. La diagnosi definitiva è stata ottenuta mediante conferma istologica e/o attraverso il follow-up di tutti i pazienti, anche di quelli non sottoposti a procedure bioptiche o ad intervento chirurgico.
Risultati
La tecnica PET è risultata avere una sensibilità pari al 94,05%, una specificità pari al 91,60% ed un’accuratezza del 93,36%; la tecnica TC una sensibilità pari al 91,07%, una specificità pari al 95,42% ed un’accuratezza del 92,29%. La tecnica combinata (PET/TC) è risultata avere una sensibilità pari al 97,92%, una specificità pari al 97,71%, ed un’accuratezza del 97,86%.
Conclusioni
La PET/TC è risultata di notevole utilità nella stadiazione e ristadiazione dei pazienti affetti da tumore del colon-retto. Essa è risultata particolarmente efficace quando, pur in presenza di un innalzamento progressivo dei marcatori, non era visualizzabile clinicamente o strumentalmente ripresa di malattia, garantendo così un’anticipazione diagnostica. La PET/TC non solo offre una performance diagnostica ottimale in termini di sensibilità e specificità, permettendo peraltro di modificare l’iter terapeutico del paziente, ma riveste anche caratteri di indagine unica di elezione, con conseguenti risparmi economici.
Similar content being viewed by others
References/Bibliografia
Parker SL, Tong T, Bolden S, Wingo PA (1997) Cancer statistics. CA Cancer J Clin 47:5–27
Piano oncologico nazionale (2004–2006) Commissione Oncologica Nazionale — Ministero Salute. D.M. 26-5-2004 p.5
Abdel-Nabi H, Doerr RJ, Lamonica DM et al (1998) Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 206:755–760
Arulampalam TH, Francis DL, Visvikis D et al (2004) FDG-PET for the preoperative evaluation of colorectal liver metastases. Eur J Surg Oncol 30:286–291
Fong Y, Cohen AM, Fortner JG et al (1997) Liver resection for colorectal metastases. J Clin Oncol 15:938–946
Wanebo HJ, Chu QD, Vezeridis MP, Soderberg C (1996) Patient selection for hepatic resection of colorectal metastases. Arch Surg 131:322–329
Selzner M, Hany TF, Wildbrett P et al (2004) Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 240:1027–1034
Gearhart SL, Frassica D, Rosen R et al (2006) Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer. Ann Surg Oncol 13:397–404
Kim EE, Chung SK, Haynie TP et al (1992) Differentiation of residual or recurrent tumors from post-treatment changes with F18 FDG PET. Radiographics 12:269–279
Rohren EM, Turkington TG, Coleman RE (2004) Clinical applications of PET in oncology. Radiology 231:305–332
Townsend DW, Cherry SR (2001) Combining anatomy and function: the path to true image fusion. Eur Radiol 11:1968–1974
Hutton BF, Braun M (2003) Software for image registration: algorithms, accuracy, efficacy. Semin Nucl Med 33:180–192
Townsend DW, Beyer T, Blodgett TM (2003) PET/CT scanners: a hardware approach to image fusion. Semin Nucl Med 33:193–204
Pauwels EK, McCready VR, Stoot JH, van Deurzen DF (1998) The mechanism of accumulation of tumour-localising radiopharmaceuticals. Eur J Nucl Med 25:277–305
Wahl RL, Hutchins GD, Buchsbaum DJ et al (1991) 18 F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography. Cancer 67:1544–1550
Lai CH, Yen TC, Chang TC (2007) Positron-emission tomography imaging for gynecologic malignancy. Curr Opin Obstet Gynecol 19:37–41
Kostakoglu L, Agress H Jr, Goldsmith SJ (2003) Clinical role of FDG PET in evaluation of cancer patients. Radiographics 23:315–340
Fong Y, Saldinger PF, Akhurst T et al (1999) Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg 178:282–287
Imdahl A, Reinhardt MJ, Nitzsche EU et al (2000) Impact of 18F-FDG-positron emission tomography for decision making in colorectal cancer recurrences. Arch Surg 385:129–134
Wiering B, Ruers TJ, Oyen WJ (2004) Role of FDG-PET in the diagnosis and treatment of colorectal liver metastases. Expert Rev Anticancer Ther 4:607–613
Kim JH, Czernin J, Allen-Auerbach MS et al (2005) Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer. J Nucl Med 46:587–595
Martinelli M, Townsend D, Meltzer C, Villemagne V (2000) Survey of results of whole body imaging using the PET/CT at the University of Pittsburgh Medical Center PET Facility. Clin Positron Imaging 3:161
Charron M, Beyer T, Bohnen NN et al (2000) Image analysis in patients with cancer studied with a combined PET and CT scanner. Clin Nucl Med 25:905–910
Cohade C, Osman M, Leal J, Wahl RL (2003) Direct comparison of (18)FFDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 44:1797–1803
Steele G Jr, Bleday R, Mayer RJ et al (1991) A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584. J Clin Oncol 9:1105–1112
Kapoor V, McCook BM, Torok FS (2004) An introduction to PET-CT imaging. Radiographics 24:523–543
Heriot AG, Grundy A, Kumar D (1999) Preoperative staging of rectal carcinoma. Br J Surg 86:17–28
Delbeke D, Martin WH (2004) PET and PET-CT for evaluation of colorectal carcinoma. Semin Nucl Med 34:209–223
Rohren EM, Paulson EK, Hagge R et al (2002) The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer. Clin Nucl Med 27:550–555
Delbeke D, Martin WH, Patton JA, Sandler MP (2001) Value of iterative reconstruction, attenuation correction, and image fusion in the interpretation of FDG PET images with an integrated dual-head coincidence camera and X-ray-based attenuation maps. Radiology 218:163–171
Flamen P (2002) Positron emission tomography in colorectal cancer. Best Pract Res Clin Gastroenterol 16:237–251
Park KC, Schwimmer J, Shepherd JE et al (2001) Decision analysis for the cost-effective management of recurrent colorectal cancer. Ann Surg 233:310–319
Berthelsen AK, Holm S, Loft A et al (2005) PET/CT with intravenous contrast cam be used for PET attenuation correction in cancer patients. Eur J Nucl Med Mol Imaging 32:1167–1175
Czernin J, Schelbert H (2004) PET/CT imaging: facts, opinions, hopes, and questions. J Nucl Med 45:1S–3S
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Orlacchio, A., Schillaci, O., Fusco, N. et al. Role of PET/CT in the detection of liver metastases from colorectal cancer. Radiol med 114, 571–585 (2009). https://doi.org/10.1007/s11547-009-0393-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11547-009-0393-7